Icecure Medical Ltd Ordinary Shares ICCM 深 沪
已收盘 08-01 16:00:00 美东时间
1.01
-0.010
-0.98%
华盛通- 最 高1.02
- 今 开1.01
- 成交量 65.99万股
- 最 低 0.9796
- 昨 收 1.02
- 总市值 6041.94万
- 52周最高 1.6288
- 市盈率 静 --
- 换手率 1.10%
- 52周最低 0.471
- 委 比 -15.54%
- 总股本 5982.12万
- 历史最高 12.167
- 量 比 0.07
- 振 幅 3.96%
- 历史最低 0.471
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多IceCure Medical Completes $10M Rights Offering To Support Tumor-Freezing Technology Expansion
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor
07-29 21:14
IceCure Medical ProSense Featured At Japanese Breast Cancer Society Conference
Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study of over
07-25 21:03
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period
CAESAREA, Israel, July 24, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology t...
07-24 21:00
IceCure Medical Announces Shareholder Meeting for August 2025
Icecure Medical ( ($ICCM) ) just unveiled an update. IceCure Medical Ltd. has a...
07-17 04:37
IceCure Medical Launches $10M Rights Offering To Fund Operations, Repay Bridge Loan
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal,
07-10 20:08
IceCure Announces Commencement of Rights Offering
CAESAREA, Israel, July 10, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology t...
07-10 20:00
IceCure Medical Launches $10M Rights Offering At $1.00/Unit; Company's Largest Shareholder, Epoch Commits Up To $5M
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal,
06-25 21:27
IceCure Medical Secures U.S. Patent Allowance for Cryogen Flow Control
An update from Icecure Medical ( ($ICCM) ) is now available. On June 9, 2025, I...
06-09 20:57
美股大行评级 | 潜在涨幅746.15%！Intrusion获Ascendiant Capital升目标价至11美元，维持"买入"评级
潜在涨幅746.15%！Intrusion获Ascendiant Capital升目标价至11美元，维持"买入"评级
06-02 13:32
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
